A promoter that drives gene expression preferentially in male transgenic rats
- 333 Downloads
Gender-preferential gene expression is a widespread phenomenon in humans. It is important to study how gender differences influence the pathogenesis of various diseases and response to specific drugs. The aim of this study is to determine if the mouse albumin enhancer/promoter may serve as the promoter to introduce gender-preferential gene expression in transgenic animals. We created four independent transgenic rat lines in which the human C-reactive protein transgene was under the control of mouse albumin enhancer/promoter. Quantitative real time RT-PCR analysis showed that transgene expression in the liver of male rats was significantly higher than transgene expression in the female rats (P < 0.05).There was a 5.3-fold (male/female) difference in line-519, and a 12.2-fold (male/female) difference in line-488. Enzyme-linked immunosorbent assay showed that the serum of male transgenic rats had a 13- to 679-fold difference at the protein level on transgene production compared with female transgenic rats. The male-to-female difference in gene expression was 10- to 17-fold in the liver of transgenic rats. Orchiectomy dramatically reduced protein production from the transgene in the liver. Testosterone administration into female rats did not increase the transgene expression, but estrogen administration into the male rats reduced transgene expression. This study provides a valuable tool for investigating the pathological roles of genes that are expressed in a gender-preferential manner in human disease.
KeywordsGender-preferential Transgenic Animal model Gene expression
This work was supported by NIH Grants (HG006173, MD005964, HL095098, RR003034), American Heart Association Grant (09GRNT2300003). We acknowledge Wanda Filipiak for preparation of transgenic rats and the Transgenic Animal Model Core of the University of Michigan’s Biomedical Research Core Facilities.
Conflict of interest
The authors have declared that no competing interests exist.
- Heidecker B, Lamirault G, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Hall J, Kittleson MM, Baughman KL, Hare JM (2010) The gene expression profile of patients with new-onset heart failure reveals important gender-preferential differences. Eur Heart J 31(10):1188–1196PubMedCentralPubMedCrossRefGoogle Scholar
- Si H, Banga RS, Kapitsinou P, Ramaiah M, Lawrence J, Kambhampati G, Gruenwald A, Bottinger E, Glicklich D, Tellis V, Greenstein S, Thomas DB, Pullman J, Fazzari M, Susztak K (2009) Human and murine kidneys show gender- and species-specific gene expression differences in response to injury. PLoS One 4(3):e4802PubMedCentralPubMedCrossRefGoogle Scholar
- Vawter MP, Evans S, Choudary P, Tomita H, Meador-Woodruff J, Molnar M, Li J, Lopez JF, Myers R, Cox D, Watson SJ, Akil H, Jones EG, Bunney WE (2004) Gender-preferential gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 29(2):373–384PubMedCentralPubMedCrossRefGoogle Scholar